Technical Analysis for NAVB - Navidea Biopharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 1.44 0.70% 0.01
NAVB closed up 0.7 percent on Monday, May 20, 2019, on 41 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Down Down Down
See historical NAVB trend table...

Date Alert Name Type % Chg
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Boomer Sell Setup Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Boomer Sell Setup Bearish Swing Setup 0.70%
Narrow Range Bar Range Contraction 0.70%

Older signals for NAVB ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents. The company's radiopharmaceutical development programs include Lymphoseek Injection, a receptor-targeted small-molecule investigational radiopharmaceutical that is used in lymphatic mapping procedures, which are performed to help stage breast cancer and melanoma; and NAV4694, an F-18 radiolabeled positron emission tomography imaging agent, which is used as an aid in the diagnosis of patients with signs or symptoms of cognitive impairment, such as Alzheimer's disease. Its radiopharmaceutical development programs also comprise NAV5001, an Iodine-123 radiolabeled single photon emission computed tomography imaging agent that is used as an aid in the diagnosis of Parkinson's disease and other movement disorders with potential use as a diagnostic aid in dementia; and RIGScan, a radiolabeled monoclonal antibody that is developed as a diagnostic aid for use during surgery to help surgeons locate occult or metastatic cancer, primarily colorectal cancer. It has research and development agreements with University of California, AstraZeneca AB, Alseres Pharmaceuticals, Inc., and The Ohio State University. The company was formerly known as Neoprobe Corporation and changed its name to Navidea Biopharmaceuticals, Inc. in January 2012. Navidea Biopharmaceuticals, Inc. was founded in 1983 and is headquartered in Dublin, Ohio.
Medicine Biopharmaceutical Surgery Alzheimer's Disease Parkinson's Disease Medical Physics Melanoma Dementia Movement Disorders Tomography Medicinal Radiochemistry Metastasis Radiopharmaceuticals Nuclear Medicine University Of California Cognitive Impairment F 18 Positron Emission Tomography Radiochemistry
Is NAVB a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 7.4
52 Week Low 1.21
Average Volume 52,812
200-Day Moving Average 3.421
50-Day Moving Average 2.689
20-Day Moving Average 2.2056
10-Day Moving Average 1.832
Average True Range 0.2799
ADX 52.36
+DI 5.6946
-DI 48.9619
Chandelier Exit (Long, 3 ATRs ) 2.7603
Chandelier Exit (Short, 3 ATRs ) 2.0497
Upper Bollinger Band 3.2095
Lower Bollinger Band 1.2017
Percent B (%b) 0.12
BandWidth 91.031919
MACD Line -0.4013
MACD Signal Line -0.3117
MACD Histogram -0.0896
Fundamentals Value
Market Cap 233.28 Million
Num Shares 162 Million
EPS 0.48
Price-to-Earnings (P/E) Ratio 3.00
Price-to-Sales 3.31
Price-to-Book 4.17
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.51
Resistance 3 (R3) 1.51 1.48 1.50
Resistance 2 (R2) 1.48 1.46 1.48 1.49
Resistance 1 (R1) 1.46 1.45 1.47 1.46 1.49
Pivot Point 1.44 1.44 1.44 1.44 1.44
Support 1 (S1) 1.41 1.42 1.43 1.42 1.39
Support 2 (S2) 1.39 1.41 1.39 1.39
Support 3 (S3) 1.37 1.39 1.38
Support 4 (S4) 1.37